# Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy, With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients

> **NCT07695272** · — · ACTIVE_NOT_RECRUITING · sponsor: **Centro Cardiologico Monzino** · enrollment: 2000 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy (HCM)
- Cardiac Myosin Inhibitors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07695272
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2031-06-01
- **Final completion:** 2031-06-01
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695272, "Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy, With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07695272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*